Inventor
REIK ANDREAS
US23 patents
⚠️ This page may combine multiple inventors who share the name “REIK ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANGAMO BIOSCIENCES INC
10 patentsUS9873894B2Jan 23, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC86 citations97
US9902974B2Feb 27, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC29 citations94
US10072062B2Sep 11, 2018
Methods and compositions for modification of a HLA locus
SANGAMO BIOSCIENCES INC11 citations84
US10046028B2Aug 14, 2018
Methods and compositions for modulating PD1
SANGAMO BIOSCIENCES INC7 citations83
US9957501B2May 1, 2018
Nuclease-mediated regulation of gene expression
SANGAMO BIOSCIENCES INC6 citations80
US10907175B2Feb 2, 2021
Isolated human cell with an inactivated glucocorticoid receptor gene
SANGAMO BIOSCIENCES INC2 citations73
US9963715B2May 8, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC3 citations73
US9650648B2May 16, 2017
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC4 citations73
US10072066B2Sep 11, 2018
Methods and compositions for treatment of a beta thalessemia
SANGAMO BIOSCIENCES INC6 citations72
US9402879B2Aug 2, 2016
Methods and compositions for modulating PD1
SANGAMO BIOSCIENCES INC2 citations62
SANGAMO THERAPEUTICS INC
9 patentsUS10196651B2Feb 5, 2019
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC16 citations94
US10196652B2Feb 5, 2019
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC11 citations92
US10808020B2Oct 20, 2020
Nuclease-mediated regulation of gene expression
SANGAMO THERAPEUTICS INC6 citations73
US10619154B2Apr 14, 2020
Nuclease-mediated regulation of gene expression
SANGAMO THERAPEUTICS INC3 citations69
US11884930B2Jan 30, 2024
Method of inactivating a glucocorticoid receptor gene in an isolated cell
SANGAMO THERAPEUTICS INC0 citations62
US11492643B2Nov 8, 2022
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC0 citations62
US11235026B2Feb 1, 2022
Methods and compositions for modulating PD1
SANGAMO THERAPEUTICS INC1 citations62
US10858416B2Dec 8, 2020
Methods and compositions for modification of a HLA locus
SANGAMO THERAPEUTICS INC1 citations62
US12516098B2Jan 6, 2026
Chimeric antigen receptor mediated cell targeting
SANGAMO THERAPEUTICS INC0 citations55